-
From the Editor-in-Chief
Cancer Research: Back to the BasicsMore basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
-
Editor's Letter
Shoot for the MoonHow can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Get Involved
The Gift of a GetawayGive patients and their families a break from cancer.
by Maria Wolf
-
Editor's Letter
Making Progress in Treating CancerCancer Today's Winter 2015/2016 issue describes advances in lung cancer, big data and more.
by Kevin McLaughlin
-
Forward Look
Should the Age to Buy Cigarettes Be 21?Q&A with CDC's Brian King on reducing teen access to tobacco products.
by Chris Palmer
-
Global Report
A Dutch DilemmaWhile much of the Western world was tightening restrictions on smoking, one European nation, the Netherlands, found itself embroiled in a political struggle between individual freedoms and public health.
by Cynthia Ryan
-
Get Involved
A Family’s TributeCindy's Legacy provides financial support to families who are affected by cancer.
by Eileen Glanton Loftus
-
Q&A
Conversation StarterCancer survivor Emily McDowell creates greeting cards that give people the words to talk about a difficult disease.
by Stephen Ornes
-
Editor's Letter
Cancer Research Needs Robust Federal FundingNow's the time to show support for medical research funding.
by Kevin McLaughlin
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles